Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
KEGG | hsa04620 | Toll-like receptor signaling pathway | 40/1836 | 104/8135 | 0.0001738 | 0.00215 | 0.001463 | 40 | RABC11 | |
KEGG | hsa04668 | TNF signaling pathway | 42/1836 | 112/8135 | 0.0002322 | 0.002595 | 0.001767 | 42 | RABC11 | |
KEGG | hsa05145 | Toxoplasmosis | 42/1836 | 112/8135 | 0.0002322 | 0.002595 | 0.001767 | 42 | RABC11 | |
KEGG | hsa05417 | Lipid and atherosclerosis | 71/1836 | 215/8135 | 0.0002397 | 0.002595 | 0.001767 | 71 | RABC11 | |
KEGG | hsa04935 | Growth hormone synthesis, secretion and action | 44/1836 | 119/8135 | 0.0002409 | 0.002595 | 0.001767 | 44 | RABC11 | |
KEGG | hsa03030 | DNA replication | 18/1836 | 36/8135 | 0.0002766 | 0.002887 | 0.001966 | 18 | RABC11 | |
KEGG | hsa05222 | Small cell lung cancer | 35/1836 | 92/8135 | 0.000549 | 0.005556 | 0.003782 | 35 | RABC11 | |
KEGG | hsa05320 | Autoimmune thyroid disease | 23/1836 | 53/8135 | 0.0005791 | 0.00568 | 0.003867 | 23 | RABC11 | |
KEGG | hsa04928 | Parathyroid hormone synthesis, secretion and action | 39/1836 | 106/8135 | 0.0005952 | 0.00568 | 0.003867 | 39 | RABC11 | |
KEGG | hsa05340 | Primary immunodeficiency | 18/1836 | 38/8135 | 0.0006405 | 0.005943 | 0.004045 | 18 | RABC11 | |
KEGG | hsa04666 | Fc gamma R-mediated phagocytosis | 36/1836 | 97/8135 | 0.0007903 | 0.007135 | 0.004857 | 36 | RABC11 | |
KEGG | hsa04657 | IL-17 signaling pathway | 35/1836 | 94/8135 | 0.0008679 | 0.007629 | 0.005193 | 35 | RABC11 | |
KEGG | hsa05171 | Coronavirus disease - COVID-19 | 73/1836 | 232/8135 | 0.000959 | 0.008205 | 0.005586 | 73 | RABC11 | |
KEGG | hsa04750 | Inflammatory mediator regulation of TRP channels | 36/1836 | 98/8135 | 0.0009827 | 0.008205 | 0.005586 | 36 | RABC11 | |
KEGG | hsa05208 | Chemical carcinogenesis - reactive oxygen species | 71/1378 | 223/8135 | 0.0000000237 | 0.00000788 | 0.00000518 | 71 | RABC86 | |
KEGG | hsa05166 | Human T-cell leukemia virus 1 infection | 69/1378 | 222/8135 | 0.000000108 | 0.0000123 | 0.0000081 | 69 | RABC86 | |
KEGG | hsa04932 | Non-alcoholic fatty liver disease | 53/1378 | 155/8135 | 0.000000111 | 0.0000123 | 0.0000081 | 53 | RABC86 | |
KEGG | hsa04660 | T cell receptor signaling pathway | 39/1378 | 104/8135 | 0.000000362 | 0.0000253 | 0.0000166 | 39 | RABC86 | |
KEGG | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 35/1378 | 89/8135 | 0.000000379 | 0.0000253 | 0.0000166 | 35 | RABC86 | |
KEGG | hsa04658 | Th1 and Th2 cell differentiation | 34/1378 | 92/8135 | 0.00000296 | 0.0001643 | 0.000108 | 34 | RABC86 | |
KEGG | hsa05169 | Epstein-Barr virus infection | 60/1378 | 202/8135 | 0.00000385 | 0.0001726 | 0.0001135 | 60 | RABC86 | |
KEGG | hsa04010 | MAPK signaling pathway | 80/1378 | 294/8135 | 0.00000461 | 0.0001726 | 0.0001135 | 80 | RABC86 | |
KEGG | hsa05170 | Human immunodeficiency virus 1 infection | 62/1378 | 212/8135 | 0.00000467 | 0.0001726 | 0.0001135 | 62 | RABC86 | |
KEGG | hsa04064 | NF-kappa B signaling pathway | 36/1378 | 104/8135 | 0.00000873 | 0.0002907 | 0.0001911 | 36 | RABC86 | |
KEGG | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 56/1378 | 194/8135 | 0.0000203 | 0.0005685 | 0.0003738 | 56 | RABC86 | |
KEGG | hsa04659 | Th17 cell differentiation | 36/1378 | 108/8135 | 0.0000226 | 0.0005685 | 0.0003738 | 36 | RABC86 | |
KEGG | hsa05020 | Prion disease | 73/1378 | 273/8135 | 0.0000231 | 0.0005685 | 0.0003738 | 73 | RABC86 | |
KEGG | hsa05014 | Amyotrophic lateral sclerosis | 92/1378 | 364/8135 | 0.000024 | 0.0005685 | 0.0003738 | 92 | RABC86 | |
KEGG | hsa05010 | Alzheimer disease | 96/1378 | 384/8135 | 0.0000256 | 0.0005685 | 0.0003738 | 96 | RABC86 | |
KEGG | hsa04151 | PI3K-Akt signaling pathway | 89/1378 | 354/8135 | 0.0000404 | 0.0007986 | 0.0005251 | 89 | RABC86 |